| INTEGRA LIFESCIENCES |
| USA |
| Gesundheit |
| US4579852082 / 897013 |
| IL3 (Frankfurt) / IART (NASDAQ) |
| FRA:IL3, ETR:IL3, IL3:GR, NASDAQ:IART |
| - |
| https://www.integralife.c.. |
|
Integra LifeSciences Holdings Corporation is a medical technology company that develops, manufactures, and markets products used in neurosurgery, regenerative medicine, and surgical reconstruction. The company’s current business is organized around..
>Volltext.. |
| 1112.72 Mio. EUR |
| 2690.87 Mio. EUR |
| 1465.11 Mio. EUR |
| 293.14 Mio. EUR |
| -6.44 Mio. EUR |
| -0.08 EUR |
| 1821.87 Mio. EUR |
| 190.66 Mio. EUR |
| 75.87 Mio. EUR |
| 0.83 |
| 1.6% |
| 98.55% |
| - |
| - |
| - |
| - |
| INTEGRA LIFESCIENCES, INTEGRA LIFE, INTEGRA LIFESCIENCE |
| 02.10.26 |
|